Effects of Empagliflozin on the Progression of Chronic Kidney Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial
Lancet Diabetes Endocrinol 2023 Dec 04;[EPub Ahead of Print], The EMPA-KIDNEY Collaborative GroupFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.